Simplex Trading’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $223K | Sell |
3,700
-47,600
| -93% | -$2.64M | ﹤0.01% | 4569 |
|
|
2026
Q1 | $2.98M | Buy |
51,300
+49,900
| +3,564% | +$2.3M | ﹤0.01% | 1507 |
|
|
2025
Q4 | $62.7K | Sell |
1,400
-14,800
| -91% | -$622K | ﹤0.01% | 5451 |
|
|
2025
Q3 | $650K | Sell |
16,200
-800
| -5% | -$28.2K | ﹤0.01% | 3513 |
|
|
2025
Q2 | $532K | Buy |
17,000
+15,400
| +963% | +$502K | ﹤0.01% | 3445 |
|
|
2025
Q1 | $53K | Sell |
1,600
-4,300
| -73% | -$163K | ﹤0.01% | 5714 |
|
|
2024
Q4 | $231K | Sell |
5,900
-11,100
| -65% | -$459K | ﹤0.01% | 4368 |
|
|
2024
Q3 | $669K | Sell |
17,000
-5,400
| -24% | -$218K | ﹤0.01% | 3290 |
|
|
2024
Q2 | $873K | Buy |
22,400
+7,400
| +49% | +$296K | ﹤0.01% | 3061 |
|
|
2024
Q1 | $645K | Buy |
15,000
+12,500
| +500% | +$575K | ﹤0.01% | 3594 |
|
|
2023
Q4 | $115K | Sell |
2,500
-28,500
| -92% | -$1.01M | ﹤0.01% | 5243 |
|
|
2023
Q3 | $1.06M | Buy |
31,000
+26,700
| +621% | +$999K | ﹤0.01% | 2606 |
|
|
2023
Q2 | $165K | Sell |
4,300
-46,800
| -92% | -$1.86M | ﹤0.01% | 4526 |
|
|
2023
Q1 | $1.83M | Sell |
51,100
-29,900
| -37% | -$1.1M | ﹤0.01% | 2024 |
|
|
2022
Q4 | $3.19M | Buy |
81,000
+79,800
| +6,650% | +$2.91M | ﹤0.01% | 1519 |
|
|
2022
Q3 | $43K | Sell |
1,200
-2,700
| -69% | -$97.1K | ﹤0.01% | 6656 |
|
|
2022
Q2 | $118K | Buy |
3,900
+1,000
| +34% | +$30.2K | ﹤0.01% | 5349 |
|
|
2022
Q1 | $88K | Sell |
2,900
-28,300
| -91% | -$847K | ﹤0.01% | 6335 |
|
|
2021
Q4 | $974K | Buy |
31,200
+30,000
| +2,500% | +$896K | ﹤0.01% | 2883 |
|
|
2021
Q3 | $22K | Buy |
1,200
+400
| +50% | +$6.95K | ﹤0.01% | 8373 |
|
|
2021
Q2 | $14K | Buy |
800
+793
| +11,329% | +$14.6K | ﹤0.01% | 8889 |
|
|
2021
Q1 | $12K | Buy |
+7
| New | +$119 | ﹤0.01% | 7815 |
|
|
2020
Q3 | – | Sell |
-3
| Closed | -$3K | – | 8649 |
|
|
2020
Q2 | $3K | Hold |
3
| – | – | ﹤0.01% | 7187 |
|
|
2020
Q1 | $3K | Buy |
+3
| New | +$43 | ﹤0.01% | 7105 |
|
|
2019
Q2 | – | Sell |
-10
| Closed | -$10K | – | 7898 |
|
|
2019
Q1 | $10K | Buy |
+10
| New | +$85 | ﹤0.01% | 6166 |
|
|
2018
Q4 | – | Sell |
-5
| Closed | -$6K | – | 7938 |
|
|
2018
Q3 | $6K | Hold |
5
| – | – | ﹤0.01% | 6706 |
|
|
2018
Q2 | $4K | Buy |
+5
| New | +$31 | ﹤0.01% | 6828 |
|
Other funds holding XENE
Simplex Trading's XENE Position: Q3 2024 in Review
Simplex Trading sold out of Xenon Pharmaceuticals (XENE) in Q3 2024, closing a stake of 2,589 shares — an estimated $104K sold.
Simplex Trading first reported a position in XENE in Q2 2020 and held it in 10 quarters. The position peaked at $1.31M in Q4 2023. 203 funds tracked by Wall St. Rank hold XENE as of Q3 2024.
- Simplex Trading reported no remaining Xenon Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
- Simplex Trading sold 2,589 Xenon Pharmaceuticals shares in Q3 2024, an estimated $104K.
- Simplex Trading first reported a position in Xenon Pharmaceuticals in Q2 2020 and held it in 10 quarters.
- Simplex Trading's Xenon Pharmaceuticals position peaked at $1.31M in Q4 2023.
- 203 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2024.
Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.